Activity of eribulin mesylate in heavily pretreated breast cancer granted access via the Cancer Drugs Fund. [electronic resource]
Producer: 20141028Description: 363-76 p. digitalISSN:- 1744-8301
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.